Post-traumatic bone infection is a common and refractory orthopedic infectious disease that can lead to bone destruction, implant failure, and repeated relapse, seriously compromising patient prognosis. Its intractability is attributable to not only drug-resistant strains but also bacterial biofilm formation and host immune dysfunction. Biofilms restrict antibiotic penetration and impair immune clearance through a dense extracellular matrix, while persistent infection further weakens the function of neutrophils, macrophages, T cells, and other immune cells, thereby creating a local microenvironment characterized by suppressive immune responses that promote infection persistence. Current studies have mainly focused on bacterial eradication, antibiotic tolerance, or the repair of bone defects. However, changes in local immune cell function after biofilm formation and their effects on infection recurrence and bone repair have not been systematically reviewed. The authors systematically elaborated on the formation, structure, and metabolic characteristics of biofilms in post-traumatic bone infection. They focused on reviewing the functional abnormalities of neutrophils, macrophages, dendritic cells, myeloid-derived suppressor cells, T cells, and B cells in the biofilm environment and analyzed the underlying mechanisms in relation to the biofilm matrix, bacterial metabolism, and regulation of bacterial virulence. On this basis, they further dicussed the therapeutic approaches, such as biofilm matrix degradation, quorum-sensing inhibition, bacteriophage therapy, local immunomodulation, and drug delivery materials, aiming to provide a reference for mechanistic studies and selection of the therapeutic strategies for post-traumatic bone infection.